Can-Fite BioPharma Ltd.
CANFNYSEAMERICANHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $6.87M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.90$12.30
- Volume (live)
- -
- Avg. volume (3M)
- 64.73K
Can-Fite BioPharma (CANF) Stock Price & Financial Analysis
Can-Fite BioPharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.87 - $1.90 |
|---|---|
| 52-Week High | $12.30 |
| 52-Week Low | $1.90 |
| Open | $1.90 |
| Volume (last close) | 27.21K |
| Average Volume (3M) | 64.73K |
| Revenue (TTM) | 405.00K |
|---|---|
| Net Income (TTM) | -9.55M |
| Free Cash Flow (TTM) | -9.51M |
| EPS (TTM) | −$0.06 |
| Profit Margin | -2358.77% |
| Operating Margin | -2402.96% |
| Return on Equity (ROE) | -196.77% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Nov 12, 2013 |
| Market Cap | 6.87M |
|---|---|
| Shares Outstanding | 3.71M |
| Price to Sales (P/S) | 16.95 |
| Price to Book (P/B) | 1.41 |
| EV/EBITDA | -0.41 |
| 50-Day MA | $2.65 |
|---|---|
| 200-Day MA | $3.35 |
| 1-Year Change | −82.87% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Can-Fite BioPharma at a Glance
As of the Oct 15, 2026 close, Can-Fite BioPharma (CANF) has a market capitalization of $6.87M. The stock trades at 16.9× sales. Over the trailing twelve months it lost $9.55M on revenue of $405.00K and burned $9.51M of free cash flow. Revenue fell 27.7% year over year.
As of its latest reported balance sheet, it holds $2.98M in cash and securities against $127.00K of debt, a net cash position of $2.86M.
Can-Fite BioPharma does not currently pay a dividend.
The share price is down 82.9% over the past year. At $1.85 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $1.90 to $12.30, below its 200-day moving average of $3.35.
Frequently Asked Questions About Can-Fite BioPharma
What is the current stock price for CANF?
As of the Oct 15, 2026 close, CANF stock trades at $1.85. The 52-week range is $1.90–$12.30, with a day range of $1.87–$1.90.
What is the P/E ratio for CANF?
The P/E ratio (Price-to-Earnings) for CANF is shown in the Key Statistics section. This valuation metric helps compare Can-Fite BioPharma Ltd. to industry peers.
Does CANF pay dividends?
Can-Fite BioPharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CANF?
Analyst ratings and recommendations for CANF are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CANF?
As of the Oct 15, 2026 close, Can-Fite BioPharma's market capitalization is $6.9M, classifying it as a micro-cap company. Can-Fite BioPharma operates in the Healthcare sector within the Biotechnology industry.